A US Multi-Site Observational Study in Patients with Unresectable and Metastatic Melanoma: The OPTIMIzE Study
Research Grant
Administered By
Duke Cancer Institute
Awarded By
Bristol-Myers Squibb Company
Start Date
March 1, 2016
End Date
February 28, 2021
Administered By
Duke Cancer Institute
Awarded By
Bristol-Myers Squibb Company
Start Date
March 1, 2016
End Date
February 28, 2021